US FDA approves Mirum's drug for rare bone disorder

The US Food and Drug Administration has ​approved Mirum Pharmaceuticals' drug ‌to treat a rare bone disorder, the regulator said on Friday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。